Home » Topics » BioWorld Science

BioWorld Science
RSS

Transgene gains clearance in France for phase I/IIa study of BT-001 for solid tumors

Jan. 19, 2021

HELP is on its way for herpetic stromal keratitis

Jan. 19, 2021

Novel GPC3/CD47 bispecific antibody shows strong antitumor activity in HCC xenografts

Jan. 19, 2021

Phase I trial of LY-CovMab in China completes enrollment

Jan. 19, 2021

New JAK inhibitors synthesized at Guangzhou Innocare Pharma Tech

Jan. 19, 2021

Guangdong Newopp Biopharmaceuticals identifies mutant KRAS inhibitors

Jan. 19, 2021

DMC recommends start of part 2 of COVA study of Sarconeos in COVID-19

Jan. 19, 2021

Hangzhou Hertz Pharmaceutical patents casein kinase 1 isoform epsilon inhibitors

Jan. 19, 2021

Preclinical data show SENS-401 reduces loss of residual hearing after cochlear implantation

Jan. 19, 2021

New CDK9/cyclin T1 inhibitors discovered at Medshine Discovery

Jan. 19, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...